Navigation Links
Medicis in Medical News

BioMarin Announces Second Quarter 2009 Financial Results

... June 30, 2009, BioMarin had cash and short and long-term investments totaling $485.3 million. During the quarter, BioMarin made the final payment to medicis of $70.6 million related to the Orapred transaction. "During the quarter, we reported encouraging results from the Phase I PEG-PAL study, initi...

Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation

... to use it. Dr. John L. LeRoy is helping Atlanta-area patients reduce the appearance of fine lines and wrinkles with the new Dysport®, licensed by medicis from French developer Ipsen. Dysport® functions much the same way as BOTOX® injections, and may now be considered one of its main competitors....

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

New Survey Reveals High Expectations for Popular Aesthetic Injections

...linum Toxin Survey NewsWorthy Analysis. February--March 2009. Data on file, medicis Pharmaceutical Corporation. 2. Kelton Research. Botulinum Toxin Survey Topline Report. February--March 2009. Data on file, medicis Pharmaceutical Corporation. Important Safety Information Dysport...

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

...d effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvederm(R) by Allergan Medical, and Restylane(R) by medicis Pharmaceutical. Hydrelle has been specifically formulated to deliver rapid results comparable to other hyaluronic acid fillers; and the lidocaine...

Hyperion Therapeutics Raises $60 Million Series C

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Joseph E. Whitters Joins MyoScience, Inc. Board of Directors

...ns in aesthetics. Major investors in MyoScience, include De Novo Ventures, Accuitive Medical Ventures, Nexus Medical Partners, Saratoga Ventures, and medicis Capital GmbH. Press Contacts: Robert M. Curtis, President and CEO MyoScience, Inc. bcurtis@myoscience.com (650) 474-2600...

Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble

...omote the Dysport(TM) brand as part of a U.S. sales agreement with the manufacturer, Ipsen. Adding Dysport(TM) to their dermal filler empire positions medicis as a formidable foe to Allergan and their arsenal of beauty treatments (Botox(R) and the Juvederm(R) hyaluronic acid gel fillers). Botox(R) by Al...
Medicis in Medical Technology

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

...al unmet needs and underserved patient populations in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

...enal excretion of phenylacetylglutamine, which is formed from phenylacetic acid and glutamine. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conducti...

RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial

... RADIESSE(R) is a registered trademark of BioForm Medical, Inc. Restylane(R) is a registered trademark of HA North American Sales AB, a subsidiary of medicis Pharmaceutical Corporation. Contact: Adam Gridley 650.286.4025 Vice President, Corporate Development BioForm Medical, Inc. ...
Medicis in Biological Technology

DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania

...e soft-tissue volume loss, thus returning the dermis to its original youthful state. Current marketed fillers include market-leader Restylane, sold by medicis Pharmaceutical, and Radiesse sold by Bioform. "We were very pleased to be selected for an investment by Ben Franklin Technology Partners as a part o...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...SI ) Imclone Systems (Nasdaq: IMCL ) Inverness Medical Innovations (Amex: IMA ) Invitrogen Corp. (Nasdaq: IVGN ) Medarex Inc. (Nasdaq: MEDX ) medicis Pharmaceutical (NYSE: MRX ) Mentor Corp. (NYSE: MNT ) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX ) PDL BioPharma, Inc. (Nasdaq: PDLI ) Pharmion C...

BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results

...demarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event

...s commitments and capitalize on the opportunity presented by our recently announced strategic collaboration with Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation," said Chris Rivera, President and CEO. "This team brings a unique and proven track record of developing, gaining regulator...

Hyperion Therapeutics Secures $40 Million In Series B Round

...confidence in Hyperion and our team," said Chris Rivera, President and CEO of Hyperion. "The funding will allow us to complete the licensing deal with medicis Pharmaceutical Corporation (see press release dated August 28, 2007), build out our management team, advance our clinical trials in UCD and HE, and be...

BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

... trademarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...
Other Tags
(Date:5/22/2015)... 22, 2015 Following yesterday’s announcement that ... with US-based health brand Nature’s Way, Marc St-Onge has ... of Ascenta Skin is an integral part of the ... this opportunity to further develop Ascenta Skin into a ... Skin is a breakthrough, anti-aging skincare supplement featuring 6 ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and fellow physicians ... D. Leffall, on Monday, May 18, with an 85th ... in the hospital’s Tower Auditorium. Leffall’s younger sister, 83-year-old ... to keep the secret. “I’d like to go in ... know something is up,” she said. , After more ...
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of Elite ... in his second year of racing in the professional division ... Department in Missoula, MT. He entered the triathlon scene in ... he has had 15 1st Place finishes. In his first ... all seven of his 2014 races, including two 2nd Place ...
(Date:5/22/2015)... May 22, 2015 Gateway Building Concepts ... renovations. The services the company specialize in include decks, ... basements, pool houses and much more. , The ... the owner of the company. It includes two geometrical ... design was thought out to be used with many ...
(Date:5/22/2015)... 22, 2015 DMG Productions announces the ... to broadcast on Friday, May 29, 2015 at 7:30 ... , In this episode Innovations will explore Interstate Restoration, ... business quickly through disaster recovery and restoration. , Additionally, ... works collaboratively to develop and deliver training and education ...
Breaking Medicine News(10 mins):Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2
(Date:4/10/2015)... , April 10, 2015 ... addition of the "Security Competitive Profiles - NEC" ... http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to supply ... to the market, with a company focus on the ... anticipated. Winning opportunities in the ...
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
Other Contents